33651500-3codeImmune sera and immunoglobulins tenders
2 open immune sera and immunoglobulins tenders right now within General anti-infectives for systemic use and vaccines. CPV 33651500-3 classifies immune sera and immunoglobulins across European public procurement.
Immune sera and immunoglobulins tenders closing soon
Sorted by deadlineRaamovereenkomst voor voor het leveren van polyvalente humane immunoglobulinen, protrombinecomplexconcentraat en fibrinogeen
Hospilim VZWTED Member StatesSource
29 Jun 2026Immunoglobulinen voor intraveneuze toediening (IVIG)
VITAZ vzwTED Member StatesSource
16 Jul 2026
By the numbers
Open now
2
Notices all-time
295
Typical value (median)
€4.0M
€3.1M – €6.7M
Last published
11 Jun 2026
Top sources
Portal BASE211
TED Member States82
PLACSP (Spain)2
Buyer and value figures for this level are aggregated from sub-codes and may be approximate.
Frequently asked questions
- What is CPV code 33651500-3?
- CPV 33651500-3 (Immune sera and immunoglobulins) is a Common Procurement Vocabulary code used across European public procurement to classify immune sera and immunoglobulins contracts. Buyers tag notices with this code so suppliers can find relevant tenders.
- How many immune sera and immunoglobulins tenders are open right now?
- Tender Radar is currently tracking 2 open immune sera and immunoglobulins (CPV 33651500-3) tenders, out of 295 notices published all-time.
- What is the typical value of a immune sera and immunoglobulins contract?
- The median estimated value of a immune sera and immunoglobulins (CPV 33651500-3) contract is around €4,000,000. Values vary widely by buyer and scope.
- Where are immune sera and immunoglobulins tenders published?
- Immune sera and immunoglobulins (CPV 33651500-3) notices are aggregated from sources including Portal BASE, TED Member States, PLACSP (Spain), alongside other European procurement portals tracked by Tender Radar.
Track immune sera and immunoglobulins tenders automatically
Tender Radar monitors CPV 33651500-3 tenders across 15+ European procurement portals and matches them to your company profile. Get relevant immune sera and immunoglobulins opportunities delivered as they publish.